post

News 15/1/2015

REGISTRATION OF NEW MEDICINES IN BRAZIL

To guarantee that all medicines entering in the Brazilian market comply with the law regarding the manufacturing procedures and effectiveness, the National Health Surveillance Agency of Brazil (ANVISA) standardized its criteria to assess quality, efficiency and safety of all medicines. In the Newsletter prepared by Almeida Advogados we approach the main issues related to these criteria, and how ANVISA performs its analysis as well..

See the complete Article clicking here.

We wish you a good reading!
 

 

Almeida Advogados´ Team

SEE ALL ARTICLES SEE ALL ARTICLES